Thursday, December 10, 2020 2:11:31 PM
# ENTX will start to take off.. FDA Approval
Trader Alert.!
https://ca.finance.yahoo.com/news/entera-bio-announces-fda-approval-133000929.html
Trader Alert.!
https://ca.finance.yahoo.com/news/entera-bio-announces-fda-approval-133000929.html
Pure Gains
Recent ENTX News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 08:15:17 PM
- Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds • GlobeNewswire Inc. • 04/02/2026 12:45:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/27/2026 08:20:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 08:09:13 PM
- Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/27/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 12:30:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2026 02:00:37 PM
- Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis • GlobeNewswire Inc. • 03/04/2026 01:30:00 PM
- Entera Bio to Participate in the Leerink Partners 2026 Global Healthcare Conference • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
- Entera Bio Names Former Pfizer Executive Geno Germano as Board Chair • IH Market News • 02/18/2026 02:11:36 PM
- Entera Bio Announces Open Market Purchases of Company Stock by Board Members • GlobeNewswire Inc. • 02/11/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:47:27 PM
- Entera Bio Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones • GlobeNewswire Inc. • 02/09/2026 01:50:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 01:46:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/04/2026 01:00:37 PM
- OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism • GlobeNewswire Inc. • 02/04/2026 01:00:00 PM
- OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism • GlobeNewswire Inc. • 02/04/2026 01:00:00 PM
- Entera Bio Announces Upcoming Q1 2026 Corporate Priorities and Pipeline Outlook • GlobeNewswire Inc. • 01/21/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 09:25:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 09:23:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 11:01:25 AM
- Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation • GlobeNewswire Inc. • 12/23/2025 01:30:00 PM
- Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program) • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference • GlobeNewswire Inc. • 11/18/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:50 PM
